View in EDS

Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.

Saved in:
Bibliographic Details
Title: Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.
Authors: Xu C; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China., Yan T; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China., Wen S; Gastroenterology Department, Henan Health Commission Key Laboratory of Gastrointestinal Cancer Prevention and Treatment, Xinxiang, China., Wu C; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China., Chang T; Gastroenterology Department, Henan Health Commission Key Laboratory of Gastrointestinal Cancer Prevention and Treatment, Xinxiang, China. ctminmail@163.com., Kong E; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China. eykong2012@163.com.; The Second Affiliated Hospital of Henan Medical University, Xinxiang, China. eykong2012@163.com., Liu H; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China. liuhuicong@xxmu.edu.cn.; The Second Affiliated Hospital of Henan Medical University, Xinxiang, China. liuhuicong@xxmu.edu.cn.
Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 May; Vol. 40 (3), pp. 459-478. Date of Electronic Publication: 2026 Apr 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-190X
DOI:10.1007/s40259-026-00769-x